ArticleDiabetes, metabolic syndrome and obesity : targets and therapy2013

Treatment outcomes after initiation of exenatide twice daily or insulin in clinical practice: 12-month results from CHOICE in six European countries.

Claes-Göran Ostenson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.